NCT06464939View on ClinicalTrials.gov

Phase 2 Study of KH001 in Long-term Relief from Dentin Hypersensitivity

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 8, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

June 30, 2025

Conditions
Dentin Hypersensitivity
Interventions
DRUG

KH001

Applications of KH001 over a 1 or 2-week period, and application of placebo

DRUG

Placebo

Applications of water for injection

Trial Locations (2)

02142

NOT_YET_RECRUITING

ADA Forsyth, Cambridge

RECRUITING

Forsyth Institute, Cambridge

All Listed Sponsors
collaborator

The Forsyth Institute

OTHER

lead

HysensBio Co., Ltd

INDUSTRY